FDA Issues Warning of Cancer Risk Tied to CAR-T Therapies

The agency has reviewed reports of cancer patients whose treatments resulted in the development of secondary blood cancers. Several companies will be required to carry the new warning.

from NYT > Health https://ift.tt/v5H07o4